MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: seminole who wrote (682)	2/17/1998 6:41:00 PM
From: the eagle	Read Replies (2) of 1826

david, the rumor was correct. what would a europe partner do for the stock if announced? having been in bioteck before i know that an announcement that phase 11 trials were to begin may still be years away from approval. so, what does this announcement do to the stock. one thing that i think is very significant is that nci interest in this new drug. i understand that nci does not even get involved unless it is a very promising drug. could someone comment. also, i am now long this stock and think it has a very bight future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next